Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
Open accessThe DOI matches its Crossref record; 79 of the 80 references it cites were found in a registry or an index.
Abstract
Context: Management of congenital adrenal hyperplasia (CAH) involves suppression of the hypothalamic–pituitary–adrenal axis using supraphysiological doses of exogenous glucocorticoids. This can pose a challenge, with Cushing syndrome a frequent complication of adequate suppression. Bilateral adrenalectomy, with subsequent replacement of glucocorticoids and mineralocorticoids at physiological doses, has been proposed as an alternative therapeutic strategy. Objective: To review the outcomes after bilateral adrenalectomy for CAH. Data Sources: A systematic search of PubMed/MEDLINE and Web of Science, identifying relevant reports published up to 10 January 2018. Study Selection: Case reports or case series were included if they reported individual patient data from patients with CAH who had undergone bilateral adrenalectomy. Data Extraction: Information regarding the following was extracted: first author, country, sex, age at adrenalectomy, year of adrenalectomy, diagnosis, molecular abnormality, pre- and postoperative biochemistry, pre- and postoperative medications, pre- and postoperative body mass index, indication for adrenalectomy, surgical technique, gross and microscopic adrenal characteristics, follow-up duration, and short- and long-term postoperative outcomes. Data Synthesis: We identified 48 cases of bilateral adrenalectomy for CAH, with patients aged from 4 months to 56 years at surgery. The most common indication for surgery was the inability to control hyperandrogenism/virilization and/or Cushing syndrome (n = 30; 62%). Most patients (n = 34; 71%) reported symptomatic improvement postoperatively, with some cases of short-term (n = 5; 10%) and long-term (n = 13; 27%) adverse outcomes. Conclusions: Bilateral adrenalectomy for CAH appears to be a reasonable therapeutic option for carefully selected patients who have had unsatisfactory outcomes with conventional medical management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Over the median follow-up of 27 months post-adrenalectomy, the mean daily hydrocortisone dose equivalency was reduced by >30% with most patients (n = 34, 71%) reporting improvements in features of hyperandrogenism, including onset or restoration of menses, and improvements in features typical of Cushing disease with subjective improvements in body image.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [145]
In the citing paper
“The two most common indications for surgery were virilization and/or iatrogenic Cushing syndrome (n = 30, 62%), followed by less common indications including benign adrenal tumour (n = 8).”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [145]
In the citing paper
“A meta-analysis evaluated the short-term and long-term outcomes of bilateral adrenalectomy as a treatment option in CAH and identified 48 patients (age at surgery 0.25–56 years) from 32 articles145.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [145]
In the citing paper
“All three patients undergoing adrenalectomy for the indication of primary infertility had a positive fertility outcome.”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [145]
In the citing paper
“Immediate postoperative complications were seen in 10% (n = 5) and long-term complications included adrenal crises in 17% (n = 8) and ectopic adrenal rest tissue in 10% (n = 5).”
From Management challenges and therapeutic advances in congenital adrenal hyperplasia (2022) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
White, P. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.3.245 · Cited by 877
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients
Arlt, W., Willis, D. S., Wild, S. H., Krone, N., Doherty, E. J., Hahner, S., Han, T. S., Carroll, P. V., Conway, G. S., Rees, D. A., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0917 · Cited by 506
Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia
Finkielstain, G. P., Kim, M. S., Sinaii, N., Nishitani, M., Van Ryzin, C., Hill, S. C., Reynolds, J. C., Hanna, R. M., & Merke, D. P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2102 · Cited by 313
Genetics of congenital adrenal hyperplasia
Krone, N., & Arlt, W. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.014 · Cited by 312
Research works printed but not linked: 2
- von M ühlendahl KE, Sippell WG. Adrenalectomy as therapy in refractory adrenogenital syndrome [in German]. Monatsschr Kinderheilkd. 1989;137(6):341-344.
- Treska V, Wirthov á M, Hadravsk á S, Mukensn ábl P, Kuntscher V, Kreuzberg B, Lis á L, Koz ák K. Giant bilateral adrenal myelolipoma associated with congenital adrenal hyperplasia [in German]. Zentralbl Chir. 2006;131(1):80-83.
Cited by
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Self-citationCongenital adrenal hyperplasia due to 21-hydroxylase deficiency
Merke, D. P., & Auchus, R. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1909786 · Cited by 341
Congenital adrenal hyperplasia
Auer, M. K., Nordenström, A., Lajic, S., & Reisch, N. (2023) · The Lancet · doi:10.1016/s0140-6736(22)01330-7 · Cited by 215
Self-citationManagement challenges and therapeutic advances in congenital adrenal hyperplasia
Mallappa, A., & Merke, D. P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00655-w · Cited by 113
Calissendorff, J., Juhlin, C. C., Sundin, A., Bancos, I., & Falhammar, H. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00178-9 · Cited by 138
Self-citationWhittle, E., & Falhammar, H. (2019) · Journal of the Endocrine Society · doi:10.1210/js.2019-00136 · Cited by 87
Self-citationAl Alawi, A. M., Nordenström, A., & Falhammar, H. (2019) · Endocrine · doi:10.1007/s12020-018-01835-3 · Cited by 77
Self-citationMANAGEMENT OF ENDOCRINE DISEASE: Gonadal dysfunction in congenital adrenal hyperplasia
Claahsen-van der Grinten, H. L., Stikkelbroeck, N., Falhammar, H., & Reisch, N. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1093 · Cited by 72
Self-citationLong-Term Outcomes of Congenital Adrenal Hyperplasia
Nordenström, A., Lajić, S., & Falhammar, H. (2022) · Endocrinology and Metabolism · doi:10.3803/enm.2022.1528 · Cited by 50
Self-citationWeidler, E. M., Grimsby, G. M., Garvey, E. M., Zwayne, N., Chawla, R., Hernandez, J., Schaub, T. A., Rink, R. C., & van Leeuwen, K. D. (2020) · Seminars in Pediatric Surgery · doi:10.1016/j.sempedsurg.2020.150929 · Cited by 43
The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum
Maher, J. Y., Gomez‐Lobo, V., & Merke, D. P. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09770-5 · Cited by 48
Pregnancy in Congenital Adrenal Hyperplasia
Reisch, N. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.011 · Cited by 36
Current and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia
Nordenström, A., Falhammar, H., & Lajić, S. (2022) · Hormone Research in Paediatrics · doi:10.1159/000522260 · Cited by 41
Self-citationUslar, T., Olmos, R. I., Martínez‐Aguayo, A., & Baudrand, R. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093128 · Cited by 49
Sarafoglou, K., Merke, D. P., Reisch, N., der Grinten, H. L. C., Falhammar, H., & Auchus, R. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad134 · Cited by 35
Self-citationNovel treatments for congenital adrenal hyperplasia
Schröder, M. A. M., & der Grinten, H. L. C. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09717-w · Cited by 35
Cardiometabolic Aspects of Congenital Adrenal Hyperplasia
Krysiak, R. G., der Grinten, H. L. C., Reisch, N., Touraine, P. A., & Falhammar, H. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae026 · Cited by 26
Self-citationRohayem, J., Bäumer, L. M., Zitzmann, M., Fricke‐Otto, S., Mohnike, K. L., Gohlke, B. C., Reschke, F., Jourdan, C., Muller, H. L., Dunstheimer, D., et al. (2021) · European Journal of Endocrinology · doi:10.1530/eje-20-1154 · Cited by 22
Future Directions for Adrenal Insufficiency: Cellular Transplantation and Genetic Therapies
Graves, L. E., Torpy, D. J., Coates, P. T., Alexander, I. E., Bornstein, S. R., & Clarke, B. M. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac751 · Cited by 24
Adrenal morphology and associated comorbidities in congenital adrenal hyperplasia
El‐Maouche, D., Hannah‐Shmouni, F., Mallappa, A., Hargreaves, C. J., Avila, N. A., & Merke, D. P. (2019) · Clinical Endocrinology · doi:10.1111/cen.13996 · Cited by 20
Burman, P., Falhammar, H., Waldenström, E., Sundin, A., & Bitzèn, U. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa870 · Cited by 19
Self-citationEmerging medical therapies for congenital adrenal hyperplasia
Speiser, P. (2019) · F1000Research · doi:10.12688/f1000research.17778.1 · Cited by 17
Clinical outcomes in 21-hydroxylase deficiency
Nordenström, A., Lajić, S., & Falhammar, H. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000625 · Cited by 15
Self-citationCongenital adrenal hyperplasia: New biomarkers and adult treatments
Dreves, B., Reznik, Y., & Tabarin, A. (2023) · Annales d Endocrinologie · doi:10.1016/j.ando.2023.01.008 · Cited by 15
Prenatal and Pregnancy Management of Congenital Adrenal Hyperplasia
Nowotny, H. F., Tschaidse, L., Auer, M. K., & Reisch, N. (2024) · Clinical Endocrinology · doi:10.1111/cen.15131 · Cited by 14
Kendırcı, H. N. P., Ünal, E., Dündar, İ., Buluş, A. D., Güneş, S. O., & Şıklar, Z. (2024) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2024.2024-6-26-s · Cited by 11
Auchus, R. J., Courtillot, C., Dobs, A. S., El‐Maouche, D., Falhammar, H., Lacroix, A., Farrar, M., O’Donoghue, C., Anatchkova, M., Cutts, K. N., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1005963 · Cited by 9
Self-citationRisk assessment, diagnosis, and treatment of cancer treatment-related adrenal insufficiency
Hayes, A. G., Rushworth, R. L., & Torpy, D. J. (2022) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2022.2023009 · Cited by 7
Emerging treatment for congenital adrenal hyperplasia
White, P. C. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000723 · Cited by 8
Goyal, A., Boro, H., & Khadgawat, R. (2019) · Cureus · doi:10.7759/cureus.5248 · Cited by 7
Agarwal, K., Ramachandran, R., Tandon, N., & Kumar, R. (2025) · Indian Journal of Urology · doi:10.4103/iju.iju_443_24 · Cited by 5
Vemula, B., Olajide, O. B., & Adepoju, Y. (2023) · Cureus · doi:10.7759/cureus.35017 · Cited by 6
Pregnancy in Congenital Adrenal Hyperplasia
Reisch, N., & Auchus, R. J. (2024) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2024.05.005 · Cited by 7
Diagnostic imaging in congenital adrenal hyperplasia – how does it help?
Gul, B., Claudette, P., Sarah, T., Anup, S., & Beharry, N. (2020) · Annals of Clinical Endocrinology and Metabolism · doi:10.29328/journal.acem.1001013 · Cited by 4
Fertility in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a review
Roszkowska, Z., Bobrowicz, M., Betlejewska, J., Hubska, J., Rak, B., & Ambroziak, U. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682341 · Cited by 5
Prevalence and Clinical Management of Adrenal Tumour-Related Hyperandrogenism: A Narrative Review
Medenica, S., Živanović, D., Milardi, D., Bruno, C., Batkoska, L., Traini, E., & Pontecorvi, A. (2024) · Life · doi:10.3390/life14030360 · Cited by 4
Adrenal disease and pregnancy: an overview
Ahmed, M., Bashir, M., Okunoye, G. O., & Konje, J. C. (2021) · The Obstetrician & Gynaecologist · doi:10.1111/tog.12761 · Cited by 3
Stuckey, B. G. A., Dedic, D., Zhang, R., Rabbah, A., Turcu, A. F., & Auchus, R. J. (2024) · JCEM Case Reports · doi:10.1210/jcemcr/luae077 · Cited by 3
Fedorova, O., & Falhammar, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1693063 · Cited by 2
Self-citationApproach to the Child and Adolescent With Adrenal Insufficiency
Patti, G., Zucconi, A., Matarese, S., Tedesco, C., Panciroli, M., Napoli, F., Iorgi, N. D., & Maghnie, M. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae564 · Cited by 5
Tulelli, B., Besançon, A., Stoupa, A., Pinto, G., Samara‐Boustani, D., Capito, C., Kariyawasam, D., Barbet, P., Taghavi, K., Sarnacki, S., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae158 · Cited by 4
La, B., Tung, C. S., Choi, E. A., & Nguyen, H. (2021) · AACE Clinical Case Reports · doi:10.1016/j.aace.2021.05.002 · Cited by 3
Polycystic Ovarian Syndrome: A Diagnosis of Exclusion
Aubuchon, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-92589-5_3 · Cited by 3
Specialty grand challenge in adrenal endocrinology
Falhammar, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1237733 · Cited by 2
Self-citationBancos, A. N., Garcia, R. G., Genere, N., Mahrokhian, S., Achenbach, S. J., Atkinson, E. J., Vaidya, A., & Bancos, I. (2026) · Journal of the Endocrine Society · doi:10.1210/jendso/bvag104
Anaforoğlu, İ., & Ertörer, M. E. (2026) · HORMONES · doi:10.1007/s42000-026-00808-w · Cited by 1
Mazzeo, P., Ceccato, F., Tizianel, I., & Barbot, M. (2025) · Case Reports in Endocrinology · doi:10.1155/crie/1422782 · Cited by 3
Management of Giant Bilateral Adrenal Myelolipomas in Congenital Adrenal Hyperplasia
Purohit, A., & Rappaport, M. J. (2025) · JCEM Case Reports · doi:10.1210/jcemcr/luaf169 · Cited by 1
Neue Behandlungsstrategien bei adrenogenitalem Syndrom/21‑Hydroxylase-Mangel
Riedl, S. (2022) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-022-00159-y · Cited by 1
O’Connell, M. A., Grover, S. R., & Bouty, A. (2020) · Springer eBooks · doi:10.1007/978-981-13-7864-5_6
Nationellt miljökvalitetsmål på lokal nivå
Engkvist, F. (2011)
Treatment of Hypertension in a Child With 11Beta-Hydroxylase Deficiency: A Case Report
Saffari, F., & Arad, B. (2022) · Journal of Pediatrics Review · doi:10.32598/jpr.10.1.993.1
Bulsari, K., & Falhammar, H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00076-5
Self-citationFunção reprodutiva em portadoras de hiperplasia adrenal congênita: revisão narrativa da literatura
Cristófalo, M. M., Andrade, S. G. D. A., Andrade, F. M., & Aldrighi, J. M. (2023) · Femina · doi:10.61622/0100-72545112202307
de la Perrière, A. B., & Martinerie, L. (2026) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/j.banm.2026.01.004
Nesbit, S. M., Shuch, B., Hamidi, S., Arasu, A., & Harari, A. (2026) · Research Square · doi:10.21203/rs.3.rs-9588169/v1
Semiz, G. G., Yılmaz, N., Aydemir, M., Selçukbiricik, Ö. S., Yürekli, B. Ş., Özışık, H., Görar, S., Yaylalı, G. F., Ertörer, E., Öner, H., et al. (2026) · Medicina · doi:10.3390/medicina62071373
Crinecerfont: emerging role in the management of congenital adrenal hyperplasia
Fedorova, O., & Falhammar, H. (2026) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2026.2713482
Self-citationApproach to the patient: the pregnant woman with congenital adrenal hyperplasia
Reisch, N., Auer, M. K., Nowotny, H. F., Welp, A.-C., Dervishi, O., Rogenhofer, N., Thaler, C., & Tschaidse, L. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag332
Metadata
- Authors
- MacKay, D., Nordenström, A., & Falhammar, H.
- Affiliations
- Royal Darwin Hospital (AU)
- Karolinska University Hospital (SE)
- Corresponding author
- MacKay, Diana
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2018-03-15
- Volume
- 103
- Issue
- 5
- Pages
- 1767-1778
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2793078239
- Cited by
- 59
- References
- 80
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 9 · 2023: 7 · 2022: 12 · 2021: 6 · 2020: 6 · 2019: 6
- FWCI
- 0.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Karolinska Institutet
- Stockholms Läns Landsting
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Keywords
- congenital adrenal hyperplasia, bilateral adrenalectomy, Cushing's syndrome, glucocorticoid replacement therapy, mineralocorticoid replacement, hyperandrogenism, masculinization, surgical outcomes
- MeSH terms
- Adolescent, Adrenal Hyperplasia, Congenital, Adrenalectomy, Adult, Child, Child, Preschool, Cushing Syndrome, Female, Fertility, Glucocorticoids, Humans, Infant, Male, Middle Aged, Mineralocorticoids, Postoperative Complications, Pregnancy, Virilism, MEDLINE, Treatment Outcome, Hyperandrogenism, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.